Literature DB >> 6197418

Human spleen cells mediating natural killing: altered natural cytotoxicity of spleen effector cells from patients with carcinoma.

S A Ali, C M Hawrylowicz, J Peel, C Griffith, R C Ress.   

Abstract

Spleen cells from eight patients with abdominal carcinoma and six patients undergoing major surgery for a variety of disease entities were assayed for natural cytotoxicity towards 51Cr-labelled K 562 target cells. Patients with abdominal cancer were shown to have relatively weak splenic natural cytotoxicity compared with the reactivity of effector cells from non-carcinoma patients. Nylon wool non-adherent spleen effector cells from cancer patients showed reduced cytolytic capacity compared with effector cells prepared from the spleens of other patients or peripheral blood mononuclear cells (PBMC) obtained from healthy individuals, whereas the splenic reactivity of non-cancer patients showed the same nylon wool separation profile as PBMC, high cytolytic activity being associated with nylon wool non-adherent effector cells. Splenic effector cell cytotoxicity from cancer and non-cancer patients was enhanced following exposure to human interferon, and inhibited by treatment with cholera toxin and simple sugars. Furthermore, fractionation of spleen cells on Percoll discontinuous density gradients demonstrated natural cytotoxic activity to reside predominantly in the low density cell fractions, similar to that found with NK cells from peripheral blood. Thus the properties described here for human cytotoxic spleen cells are similar to those described for peripheral blood NK cells, suggesting these two effector cell populations to be closely related, if not identical.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197418     DOI: 10.1007/bf00402609

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  33 in total

1.  Innate cytotoxicity of CBA mouse spleen cells to Sendai virus-infected L cells.

Authors:  M J Anderson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

2.  Reactivity of lymphocytes from normal persons on cultured tumor cells.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  A modified short-term cytotoxicity test: assessment of natural cell-mediated cytotoxicity in whole blood.

Authors:  R C Rees; A A Platts
Journal:  J Immunol Methods       Date:  1983-08-12       Impact factor: 2.303

4.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets.

Authors:  T Timonen; E Saksela; A Ranki; P Häyry
Journal:  Cell Immunol       Date:  1979-11       Impact factor: 4.868

5.  Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.

Authors:  H W Ziegler; N E Kay; J M Zarling
Journal:  Int J Cancer       Date:  1981-03-15       Impact factor: 7.396

6.  Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon.

Authors:  S Einhorn; H Blomgren; H Strander
Journal:  Int J Cancer       Date:  1980-10-15       Impact factor: 7.396

7.  Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression.

Authors:  M Takasugi; A Ramseyer; J Takasugi
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

8.  Isolation of human and rat natural killer cells.

Authors:  T Timonen; C W Reynolds; J R Ortaldo; R B Herberman
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

9.  Activation and role of natural killer cells in virus infections.

Authors:  C A Biron; R M Welsh
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

10.  Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.

Authors:  D Santoli; G Trinchieri; F S Lief
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

View more
  1 in total

Review 1.  [Role of the spleen in tumor surgery].

Authors:  U Wolters; H W Keller; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.